Do Traders Think Vaxxinity Inc (VAXX) Can Keep Climbing Wednesday?

Overall market sentiment has been high on Vaxxinity Inc (VAXX) stock lately. VAXX receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.

Vaxxinity Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on VAXX!

See Full VAXX Report

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score. As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With VAXX Stock Today?

Vaxxinity Inc (VAXX) stock has fallen -1.42% while the S&P 500 has gained 0.97% as of 2:56 PM on Wednesday, Feb 1. VAXX is lower by -$0.06 from the previous closing price of $4.00 on volume of 161,970 shares. Over the past year the S&P 500 has fallen -8.84% while VAXX is lower by -34.11%. VAXX lost -$0.61 per share in the over the last 12 months. To screen for more stocks like Vaxxinity Inc click here.

More About Vaxxinity Inc

Vaxxinity Inc is engaged in the development and commercialization of prophylactic and therapeutic vaccines to combat chronic disorders and infectious diseases with large patient populations and unmet medical needs. Its pipeline primarily consists of five programs focused on chronic disease, particularly neurodegenerative disorders, in addition to other neurology and cardiovascular indications. Click Here to get the full Stock Report for Vaxxinity Inc stock.